CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MIV Therapeutics Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MIV Therapeutics Inc.
Unit 1 8765 Ash Street
Phone: (604) 301-9545p:604 301-9545 Vancouver, BC  V6P 6T3  Canada Ticker: MIV MIV

On 1/17/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of MIV Therapeutics Inc. for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
MIV Therapeutics Inc. (MIVT) is an advanced stage, research and development company pursuing the commercialization of the next-generation biocompatible coatings for stents and other medical devices, and advanced drug delivery systems with the intent of providing healing solutions for cardiovascular disease and other medical conditions. In collaboration with the University of British Columbia (UBC), the Company has developed coating technologies that utilize Hydroxyapatite (HAp) for application on medical devices and drug delivery systems. Simultaneously, alternative polymer-free coatings and advanced polymeric coatings with enhanced biocompatibility and bioavailability were developed at its wholly owned subsidiary, MIVI Technologies Inc.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
11/30/20085/31/2008YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, CEO, Chief Financial Officer, Treasurer, Secretary ChrisChen 2/4/2011 3/15/2010

Business Names
Business Name
Biosync Scientific
Biosync Scientific Pvt. Ltd.
M&G Income Investment Co. PLC
5 additional Business Names available in full report.

General Information
Number of Employees: 115 (As of 5/31/2008)
Outstanding Shares: 20,286,062 (As of 1/16/2009)
Shareholders: 194
Stock Exchange: OTC
Federal Tax Id: 010809204
Fax Number: (604) 301-9546


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023